Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 138 (5) , 694-698
- https://doi.org/10.1067/mpd.2001.112899
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-Term Effects of Budesonide or Nedocromil in Children with AsthmaNew England Journal of Medicine, 2000
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Exhaled nitric oxide before and after montelukast sodium therapy in school-age children with chronic asthma: A preliminary studyPediatric Pulmonology, 1999
- NO in Exhaled Air of Asthmatic Children Is Reduced by the Leukotriene Receptor Antagonist MontelukastAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Benefits and risks of inhaled glucocorticoids in children with persistent asthma☆☆☆★Journal of Allergy and Clinical Immunology, 1998
- Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthmaThe Journal of Pediatrics, 1998
- Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthmaThe Journal of Pediatrics, 1998
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with AsthmaNew England Journal of Medicine, 1997
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995